These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2868746)

  • 1. Lack of effect of nizatidine on hepatic drug metabolism in man.
    Secor JW; Speeg KV; Meredith CG; Johnson RF; Snowdy P; Schenker S
    Br J Clin Pharmacol; 1985 Dec; 20(6):710-3. PubMed ID: 2868746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nizatidine, a new histamine H2-receptor antagonist, and hepatic oxidative drug metabolism in the rat: a comparison with structurally related compounds.
    Meredith CG; Speeg KV; Schenker S
    Toxicol Appl Pharmacol; 1985 Feb; 77(2):315-24. PubMed ID: 2858133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of effect of nizatidine on drug metabolism.
    Klotz U
    Scand J Gastroenterol Suppl; 1987; 136():18-23. PubMed ID: 2892251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of five structurally diverse H2-receptor antagonists on drug metabolism.
    Pasanen M; Arvela P; Pelkonen O; Sotaniemi E; Klotz U
    Biochem Pharmacol; 1986 Dec; 35(24):4457-61. PubMed ID: 2878667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of histamine H2-receptor antagonists on the hepatic elimination of drugs].
    Klotz U; Reimann I
    Klin Wochenschr; 1983 Jul; 61(13):625-32. PubMed ID: 6136626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of influenza virus vaccine on hepatic drug metabolism.
    Meredith CG; Christian CD; Johnson RF; Troxell R; Davis GL; Schenker S
    Clin Pharmacol Ther; 1985 Apr; 37(4):396-401. PubMed ID: 3979001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of interaction between nizatidine and warfarin during chronic administration.
    Cournot A; Berlin I; Sallord JC; Singlas E
    J Clin Pharmacol; 1988 Dec; 28(12):1120-2. PubMed ID: 2907521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do nizatidine and cimetidine interact with ibuprofen?
    Forsyth DR; Jayasinghe KS; Roberts CJ
    Eur J Clin Pharmacol; 1988; 35(1):85-8. PubMed ID: 2905991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nocturnal doses of ranitidine and nizatidine do not affect the disposition of diazepam.
    Klotz U; Gottlieb W; Keohane PP; Dammann HG
    J Clin Pharmacol; 1987 Mar; 27(3):210-2. PubMed ID: 2890666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nizatidine, an H2-blocker. Its metabolism and disposition in man.
    Knadler MP; Bergstrom RF; Callaghan JT; Rubin A
    Drug Metab Dispos; 1986; 14(2):175-82. PubMed ID: 2870891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of famotidine on oxidative drug metabolism.
    Somerville KW; Kitchingman GA; Langman MJ
    Eur J Clin Pharmacol; 1986; 30(3):279-81. PubMed ID: 2874031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carrier-mediated active transport of histamine H2 receptor antagonists, cimetidine and nizatidine, into isolated rat hepatocytes: contribution of type I system.
    Nakamura H; Sano H; Yamazaki M; Sugiyama Y
    J Pharmacol Exp Ther; 1994 Jun; 269(3):1220-7. PubMed ID: 7912279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nocturnal acid suppression with a new H2 receptor antagonist--nizatidine.
    Dammann HG; Gottlieb WR; Walter TA; Dreyer M; Müller P; Simon B; Keohane P
    Hepatogastroenterology; 1986 Oct; 33(5):217-20. PubMed ID: 2879782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pharmacokinetic profile of nizatidine in man.
    Callaghan JT; Bergstrom RF; Rubin A; Chernish S; Crabtree R; Knadler MP; Obermeyer B; Offen WW; Schneck DW; Aronoff G
    Scand J Gastroenterol Suppl; 1987; 136():9-17. PubMed ID: 2892261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inhibition of 24-hour acidity by nizatidine].
    Dammann HG; Dreyer M; Gottlieb WR; Wolf N; Müller P; Simon B
    Fortschr Med; 1989 May; 107(14):321-4. PubMed ID: 2568971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twenty four hour intragastric acidity and plasma gastrin concentration in healthy volunteers taking nizatidine 150 mg, nizatidine 300 mg, ranitidine 300 mg, or placebo at 21:00 h.
    Lanzon-Miller S; Pounder RE; Chronos NA; Raymond F; Hamilton MR; Dalgleish D
    Gut; 1988 Oct; 29(10):1364-9. PubMed ID: 2904394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Actions of nizatidine, a selective histamine H2-receptor antagonist, on gastric acid secretion in dogs, rats and frogs.
    Lin TM; Evans DC; Warrick MW; Pioch RP
    J Pharmacol Exp Ther; 1986 Nov; 239(2):406-10. PubMed ID: 2877081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. General pharmacology of nizatidine in animals.
    Bemis K; Bendele A; Clemens J; Deldar A; Gidda J; Hamelink J; Holland D; Lamishaw B; McGrath J; Shannon H
    Arzneimittelforschung; 1989 Feb; 39(2):240-50. PubMed ID: 2567169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of nizatidine with the three other histamine receptor antagonists for duodenal ulcer therapy.
    Lima M; Holdcroft C
    Nurse Pract; 1989 Feb; 14(2):41-2. PubMed ID: 2564655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cimetidine versus famotidine: the effect on the pharmacokinetics of theophylline in rats.
    Mojaverian P; Rocci ML; Saccar CL; Vlasses PH; Ferguson RK
    Eur J Drug Metab Pharmacokinet; 1985; 10(2):155-9. PubMed ID: 2864251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.